Meredith McMorrow

Meredith McMorrow publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Meredith McMorrow sits on this spectrum.

Meredith McMorrow D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Meredith McMorrow sits on this spectrum.

Best Publications

• Seasonality of Respiratory Syncytial Virus — United States, 2017–2023

  Unknown

  348
  Citations

• Hospitalizations of Children and Adolescents with Laboratory-Confirmed COVID-19 — COVID-NET, 14 States, July 2021–January 2022

  Unknown

  337
  Citations

• Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023

  Unknown

  316
  Citations

• Hospitalizations Associated with COVID-19 Among Children and Adolescents - COVID-NET, 14 States, March 1, 2020-August 14, 2021.

  Miranda J Delahoy;Dawud Ujamaa;Michael Whitaker;Alissa O'Halloran

  265
  Citations

• COVID-19-Associated Hospitalizations Among Vaccinated and Unvaccinated Adults 18 Years or Older in 13 US States, January 2021 to April 2022

  Unknown

  258
  Citations

• Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus–Associated Lower Respiratory Tract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023

  Unknown

  249
  Citations

• SARS-CoV-2 incidence, transmission, and reinfection in a rural and an urban setting: results of the PHIRST-C cohort study, South Africa, 2020–21

  Unknown

  199
  Citations

• Outbreak of Variant Influenza A(H3N2) Virus in the United States

  Michael A. Jhung;Scott Epperson;Matthew Biggerstaff;Donna Allen

  198
  Citations

• Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated Hospitalization Among Immunocompetent Adults Aged ≥65 Years — IVY Network, 18 States, September 8–November 30, 2022

  Unknown

  191
  Citations

• Effectiveness of mRNA Vaccination in Preventing COVID-19–Associated Invasive Mechanical Ventilation and Death — United States, March 2021–January 2022

  Unknown

  185
  Citations

• Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults - Nine States, January-September 2021.

  Peter J Embi;Matthew E Levy;Allison L Naleway;Palak Patel

  184
  Citations

• Early Estimate of Nirsevimab Effectiveness for Prevention of Respiratory Syncytial Virus–Associated Hospitalization Among Infants Entering Their First Respiratory Syncytial Virus Season — New Vaccine Surveillance Network, October 2023–February 2024

  Unknown

  181
  Citations

• Challenges in routine implementation and quality control of rapid diagnostic tests for malaria--Rufiji District, Tanzania.

  Unknown

  167
  Citations

• Vaccine effectiveness of primary series and booster doses against covid-19 associated hospital admissions in the United States: living test negative design study

  Unknown

  164
  Citations

• Respiratory Virus Surveillance Among Children with Acute Respiratory Illnesses — New Vaccine Surveillance Network, United States, 2016–2021

  Unknown

  164
  Citations

• Decline of influenza and respiratory syncytial virus detection in facility-based surveillance during the COVID-19 pandemic, South Africa, January to October 2020.

  Stefano Tempia;Sibongile Walaza;Sibongile Walaza;Jinal N Bhiman;Meredith L McMorrow

  152
  Citations

• Comparative Effectiveness and Antibody Responses to Moderna and Pfizer-BioNTech COVID-19 Vaccines among Hospitalized Veterans — Five Veterans Affairs Medical Centers, United States, February 1–September 30, 2021

  Unknown

  138
  Citations

• COVID-19 Surveillance After Expiration of the Public Health Emergency Declaration ― United States, May 11, 2023

  Unknown

  135
  Citations

• Asymptomatic transmission and high community burden of seasonal influenza in an urban and a rural community in South Africa, 2017-18 (PHIRST): a population cohort study.

  Cheryl Cohen;Cheryl Cohen;Jackie Kleynhans;Jocelyn Moyes;Jocelyn Moyes;Meredith L McMorrow

  130
  Citations

• Effectiveness of COVID-19 mRNA Vaccines Against COVID-19-Associated Hospitalization - Five Veterans Affairs Medical Centers, United States, February 1-August 6, 2021.

  Kristina L Bajema;Rebecca M Dahl;Mila M Prill;Elissa Meites

  106
  Citations